Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$15.81 USD
+0.16 (1.02%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $15.80 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
Arcus Biosciences, Inc. [RCUS]
Reports for Purchase
Showing records 41 - 60 ( 122 total )
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- EORTC-NCI-AACR 2022: Covered Companies Roundup
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; ARC-7 Data Ahead; Broad TIGIT Plan Continues Expansion
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE- The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
AB521 Demonstrates Promising Profile; Clinical Program on Track
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Partner Gilead Set for Dom Decision; Quemli Update Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R